Edit Content
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Cancer Biologics Market to reach USD XX billion by the end of 2030.

Global Cancer Biologics Market Size study & Forecast, by Product (Monoclonal Antibodies, Cytokine-Based Immunotherapy, Cancer Vaccines, CAR-T Cell Therapy, and Immune Checkpoint Inhibitors), by Application (Non-small Cell Lung Cancer, Prostate Cancer, Breast Cancer, Acute Myeloid Leukemia, Lymphoma, Others), by Distribution Channel (Hospitals, Clinics, and Others) and Regional Analysis, 2023-2030

Product Code: HLSDT-81709612
Publish Date: 1-07-2023
Page: 200

Global Cancer Biologics Market is valued at approximately USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-2030. Cancer biologics refer to a class of drugs that are designed to target specific molecules or pathways involved in the growth and spread of cancer cells. They are typically derived from living organisms, such as proteins, antibodies, and vaccines, and are designed to interact with specific targets on cancer cells. These drugs are often used in the treatment of various types of cancer and may be used alone or in combination with other treatments, such as chemotherapy, radiation therapy, or surgery. Cancer biologics may also be referred to as biologic therapies, biotherapeutics, or targeted therapies. The major driving factors for the Global Cancer Biologics Market are increasing incidences of cancer and increasing demand for targeted and personalized medicine. Moreover, technological advancements and favorable regulatory environment are creating lucrative growth opportunities in the market over the forecast period 2023-2030.

The rising incidences of cancer are one of the primary drivers of the cancer biologics market. Globally, the number of new cases of cancer was 19.3 million in 2020, according to the GLOBOCAN 2020 statistics. This number is expected to increase to 30.2 million by 2040. This significant rise in cancer cases underscores the urgent need for effective cancer treatments, including small molecule drugs, which have shown promise in the treatment of various types of cancer. However, the high cost of Cancer Biologics stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Cancer Biologics Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. The North American market for cancer biologics is expected to be the largest due to the presence of major pharmaceutical companies, high healthcare expenditure, and increasing cancer prevalence. The US is expected to dominate the market due to the high adoption rate of advanced cancer treatments. The Asia-Pacific market for cancer biologics is expected to witness significant growth due to factors such as increasing cancer prevalence, improving healthcare infrastructure, and increasing investment in R&D. China and Japan are expected to be the major contributors to the market growth.

Major market players included in this report are:
Roche Holding AG
Novartis AG
Merck & Co., Inc.
Bristol-Myers Squibb Company
Amgen Inc.
Johnson & Johnson
Pfizer Inc.
AstraZeneca plc
Eli Lilly and Company
AbbVie Inc.

Recent Developments in the Market:
Ø In January 2020, F. Hoffmann-La Roche AG announced that it had submitted a supplemental biological license application to the U.S. Food and Drug Administration (FDA) for Tecentriq (atezolizumab), in combination with the drug Avastin (bevacizumab), for the treatment of the most common form of liver cancer.

Global Cancer Biologics Market Report Scope:
ü Historical Data – 2020 – 2021
ü Base Year for Estimation – 2022
ü Forecast period – 2023-2030
ü Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
ü Segments Covered – Product, Application, Distribution Channel, Region
ü Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa
ü Customization Scope – Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:
Monoclonal Antibodies
Cytokine-Based Immunotherapy
Cancer Vaccines
CAR-T Cell Therapy
Immune Checkpoint Inhibitors

By Application:
Non-small Cell Lung Cancer
Prostate Cancer
Breast Cancer
Acute Myeloid Leukemia
Lymphoma
Others

By Distribution Channel:
Hospitals
Clinics
Others

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Cancer Biologics Market, by Region, 2020-2030 (USD Billion)
1.2.2. Cancer Biologics Market, by Product, 2020-2030 (USD Billion)
1.2.3. Cancer Biologics Market, by Application, 2020-2030 (USD Billion)
1.2.4. Cancer Biologics Market, by Distribution Channel, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Cancer Biologics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Cancer Biologics Market Dynamics
3.1. Cancer Biologics Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing Incidence of cancer
3.1.1.2. Increasing demand for targeted and personalized medicine
3.1.2. Market Challenges
3.1.2.1. High Cost of Cancer Biologics
3.1.3. Market Opportunities
3.1.3.1. Technological advancements
3.1.3.2. Favorable regulatory environment
Chapter 4. Global Cancer Biologics Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Cancer Biologics Market, by Product
5.1. Market Snapshot
5.2. Global Cancer Biologics Market by Product, Performance – Potential Analysis
5.3. Global Cancer Biologics Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
5.4. Cancer Biologics Market, Sub Segment Analysis
5.4.1. Monoclonal Antibodies
5.4.2. Cytokine-Based Immunotherapy
5.4.3. Cancer Vaccines
5.4.4. CAR-T Cell Therapy
5.4.5. Immune Checkpoint Inhibitors
Chapter 6. Global Cancer Biologics Market, by Application
6.1. Market Snapshot
6.2. Global Cancer Biologics Market by Application, Performance – Potential Analysis
6.3. Global Cancer Biologics Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
6.4. Cancer Biologics Market, Sub Segment Analysis
6.4.1. Non-small Cell Lung Cancer
6.4.2. Prostate Cancer
6.4.3. Breast Cancer
6.4.4. Acute Myeloid Leukemia
6.4.5. Lymphoma
6.4.6. Others
Chapter 7. Global Cancer Biologics Market, by Distribution Channel
7.1. Market Snapshot
7.2. Global Cancer Biologics Market by Distribution Channel, Performance – Potential Analysis
7.3. Global Cancer Biologics Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Billion)
7.4. Cancer Biologics Market, Sub Segment Analysis
7.4.1. Hospitals
7.4.2. Clinics
7.4.3. Others
Chapter 8. Global Cancer Biologics Market, Regional Analysis
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Cancer Biologics Market, Regional Market Snapshot
8.4. North America Cancer Biologics Market
8.4.1. U.S. Cancer Biologics Market
8.4.1.1. Product breakdown estimates & forecasts, 2020-2030
8.4.1.2. Application breakdown estimates & forecasts, 2020-2030
8.4.1.3. Distribution Channel breakdown estimates & forecasts, 2020-2030
8.4.2. Canada Cancer Biologics Market
8.5. Europe Cancer Biologics Market Snapshot
8.5.1. U.K. Cancer Biologics Market
8.5.2. Germany Cancer Biologics Market
8.5.3. France Cancer Biologics Market
8.5.4. Spain Cancer Biologics Market
8.5.5. Italy Cancer Biologics Market
8.5.6. Rest of Europe Cancer Biologics Market
8.6. Asia-Pacific Cancer Biologics Market Snapshot
8.6.1. China Cancer Biologics Market
8.6.2. India Cancer Biologics Market
8.6.3. Japan Cancer Biologics Market
8.6.4. Australia Cancer Biologics Market
8.6.5. South Korea Cancer Biologics Market
8.6.6. Rest of Asia Pacific Cancer Biologics Market
8.7. Latin America Cancer Biologics Market Snapshot
8.7.1. Brazil Cancer Biologics Market
8.7.2. Mexico Cancer Biologics Market
8.8. Middle East & Africa Cancer Biologics Market
8.8.1. Saudi Arabia Cancer Biologics Market
8.8.2. South Africa Cancer Biologics Market
8.8.3. Rest of Middle East & Africa Cancer Biologics Market

Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Roche Holding AG
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Recent Developments
9.3.2. Novartis AG
9.3.3. Merck & Co., Inc.
9.3.4. Bristol-Myers Squibb Company
9.3.5. Amgen Inc.
9.3.6. Johnson & Johnson
9.3.7. Pfizer Inc.
9.3.8. AstraZeneca plc
9.3.9. Eli Lilly and Company
9.3.10. AbbVie Inc.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now